Natalya
Natalya Griko, Lewisville, TX US
Patent application number | Description | Published |
---|---|---|
20100119556 | METHODS AND COMPOSITIONS FOR MODULATING AN IMMUNE RESPONSE WITH IMMUNOGENIC OLIGONUCLEOTIDES - This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided. | 05-13-2010 |
20130004538 | METHODS AND COMPOSITIONS FOR MODULATING AN IMMUNE RESPONSE WITH IMMUNOGENIC OLIGONUCLEOTIDES - This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided. | 01-03-2013 |
20150342980 | METHODS AND COMPOSITIONS FOR MODULATING AN IMMUNE RESPONSE WITH IMMUNOGENIC OLIGONUCLEOTIDES - This document relates to compositions and methods for modulating an immune response. For example, compositions of immunostimulatory CpG oligonucleotides derived from retroviral genomes are provided. | 12-03-2015 |
Natalya Ioudina, London CA
Patent application number | Description | Published |
---|---|---|
20140023620 | PROBIOTIC COMPOSITION - Disclosed herein are probiotic compositions comprising a mixture of at least two probiotic bacteria, including | 01-23-2014 |
Natalya Klimochkin, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20090276810 | RECEIVER UNIT CHANGING BETWEEN A HIGH DEFINITION MODE AND STANDARD MODE AND METHOD THEREFOR - A system and method of switching services in a receiver unit includes a verifier module in the receiver unit receiving a service signal and middleware within the receiving unit receiving an evaluate signal and enabling the verifier to determine a service change from the service signal. The middleware changing a service flag for the service when a service change is determined at the verifier. | 11-05-2009 |
Natalya Koryabkina, Alvin, TX US
Patent application number | Description | Published |
---|---|---|
20080317656 | Process of Catalytic Ammoxidation for Hydrogen Cyanide Production - A process for the ammoxidation of an alcohol feed, such as methanol, or a nitrile feed, such as propionitrile, or a mixture thereof, to form hydrogen cyamide uses a modified Mn—P catalyst having the following empirical formula: | 12-25-2008 |
Natalya Koryabkina, Worcester, MA US
Patent application number | Description | Published |
---|---|---|
20090200233 | METHODS AND DEVICES FOR THE REMOVAL OF ORGANIC CONTAMINANTS FROM WATER - Compositions, methods and devices for the removal of organic contaminants from fluids using hydrophobic micro-porous adsorbents, which are regenerated by advanced oxidation. | 08-13-2009 |
Natalya Lazareva, Moscow RU
Patent application number | Description | Published |
---|---|---|
20160058850 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES OF INFECTIOUS AND NON-INFECTIOUS ORIGIN - The present invention is based, in part, on our analysis of C1-INH levels in various patient populations. Accordingly, in a first aspect, the invention features methods for assessing the protective capacity of endogenous C1-INH in a patient who has been diagnosed with ARDS, sepsis or a sepsis-related condition, a burn or a burn-related condition, SJS, CABG-related states and/or other traumatic injuries. The methods can include the steps of: (a) providing a fluid sample from the patient; (b) determining the amount of C1-INH functional activity in the sample; and (c) comparing the amount of C1-INH functional activity to a reference standard. Where the level of C1-INH functional activity is comparable to that within a healthy patient population, the patient's own protective capacity is compromised. | 03-03-2016 |
Natalya Lozovaya, Marseille FR
Patent application number | Description | Published |
---|---|---|
20150119352 | DINUCELOSIDE POLYPHOSPHATES FOR THE TREATMENT OF PAIN - The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use in the inhibition (or down-regulation) of a pain, via a transducing ATP-gated P2X3 receptor, often by means of high-affinity desensitisation (HAD) mechanism. | 04-30-2015 |
Natalya Lozovaya, London GB
Patent application number | Description | Published |
---|---|---|
20080319184 | Uses of Dinucleotide Polyphosphate Derivatives - The present invention provides the use of analogues and derivatives of dinucleoside polyphosphates with formula (I) or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for use in one or more of: the treatment of ischemia, inducing ischemic tolerance, modulating cerebral ischemia, to delay the onset of a hypoxic depolarisation stage when ischemic events are initiated; as a neurological protection agent; as a tissue protection agent; the treatment of pain; and the treatment of inflammation, wherein X, is selected from wherein X | 12-25-2008 |
Natalya Markhotina, Woolloomooloo AU
Patent application number | Description | Published |
---|---|---|
20090123379 | NOVEL SCREENS TO IDENTIFY AGENTS THAT MODULATE RETINAL BLOOD VESSEL FUNCTION AND PERICYTE FUNCTION AND DIAGNOSTIC AND THERAPEUTIC APPLICATION THEREFOR - The present invention provides methods for determining or identifying compounds that modulate the function of an isolated retinal pericyte or blood vessel, wherein a change in the contractile state of said pericyte or blood vessel is determined in the presence of a test compound, said change indicating that the test compound modulates the function of pericytes and/or blood vessels. | 05-14-2009 |
20110206612 | NOVEL SCREENS TO IDENTIFY AGENTS THAT MODULATE RETINAL BLOOD VESSEL FUNCTION AND PERICYTE FUNCTION AND DIAGNOSTIC AND THERAPEUTIC APPLICATION THEREFOR - The present invention provides methods for determining or identifying compounds that modulate the function of an isolated retinal pericyte or blood vessel, wherein a change in the contractile state of said pericyte or blood vessel is determined in the presence of a test compound, said change indicating that the test compound modulates the function of pericytes and/or blood vessels. | 08-25-2011 |
Natalya Narizhneva, West Seneca, NY US
Patent application number | Description | Published |
---|---|---|
20120264771 | Method for Treating Androgen Receptor Positive Cancers - Provided is a method of inhibiting growth of androgen receptor positive cancer cells. The method entails administering to an individual diagnosed with or suspected of having an androgen receptor positive cancer and administering to the individual a composition containing a compound that can inhibit the growth of the androgen receptor positive cancer. | 10-18-2012 |
Natalya Ossina, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20090053688 | METHOD AND DEVICE FOR ULTRASOUND ASSISTED PARTICLE AGGLUTINATION ASSAY - Ultrasound-assisted particle agglutination assay methods and apparatuses are described based on first providing a standing wave ultrasound field at a resonance frequency of a test liquid in a resonator cell containing microparticles covered with a binding agent with high affinity to an analyte sought to be detected by the assay test. Formation of the specifically-bound and nonspecifically-bound aggregates of these microparticles is then followed by effective stirring of the liquid with swept-frequency sonication causing disintegration of nonspecifically-bound aggregates and leaving specifically-bound aggregates in place for further detection and measurement. The methods and devices of the invention allow significant improvement in the sensitivity and specificity of agglutination tests and are advantageously applicable to detecting various proteins, DNA, RNA and other biologically active substances. Specific examples are provided. | 02-26-2009 |
20100068711 | Methods of PCR-Based Detection of "Ultra Short" Nucleic Acid Sequences - The present invention provides highly sensitive methods used for diagnosing and monitoring various diseases and disorders by detecting and analyzing “ultra short” (20-50 base pair) nucleic acids obtained from bodily fluids. | 03-18-2010 |
20140363807 | Genetic Marker for Detection of Human Papillomavirus - The invention provides compositions and methods for the differential detection of high risk forms of HPV from a urine sample provided by a patient. Specifically, the invention provides primers and probes that specifically recognize and bind sequences within the E1 gene of HPV. Detection of high risk forms of HPV identifies individuals at risk of developing or in the early stages of cervical carcinoma. | 12-11-2014 |
Natalya Shpolyansky, Campbell, CA US
Patent application number | Description | Published |
---|---|---|
20150104758 | System And Interface For Patient Discharge - A system for providing post-operative instructions to patients for discharge from a medical facility comprising a repository of instructions consisting of patient-anonymous data and a graphical user interface, the graphical user interface operative for selecting at least one instruction from the repository to assemble a tutorial. The system includes a memory for storing the tutorial, each tutorial associated with a particular user profile and a display, the display presenting the tutorial to the patient. The system further includes a questionnaire to assess patient comprehension of the tutorial, and a calendar module, the calendar module configured to schedule reminder notifications for communication to the patient. An analytics module is also provided, the analytics module configured to analyze patient questionnaire responses and determine optimal tutorial content. | 04-16-2015 |
Natalya Shub, Allentown, PA US
Patent application number | Description | Published |
---|---|---|
20100125097 | COMPOSITIONS COMPRISING AN ARYL PYRAZOLE AND/OR A FORMAMIDINE, METHODS AND USES THEREOF - This invention relates to compositions for combating parasites in animals, comprising 1-arylpyrazole compounds alone or in combination with formamidine compounds. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infestation in an animal comprising administering the compositions of the invention to the animal in need thereof. | 05-20-2010 |
20130065846 | PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF - This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof. | 03-14-2013 |
20130256170 | COMPOSITIONS COMPRISING AN ARYL PYRAZOLE AND/OR A FORMAMIDINE, METHODS AND USES THEREOF - This invention relates to compositions for combating parasites in animals, comprising 1-arylpyrazole compounds alone or in combination with formamidine compounds. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infestation in an animal comprising administering the compositions of the invention to the animal in need thereof. | 10-03-2013 |
20150201611 | TOPICAL DELIVERY FORMULATION - The invention is a pour-on antiparasitic formulation having superior water resistant properties. The pour-on formulation utilizes one or more polymers (water insoluble with or without water soluble) in the range of about 5 to about 40% w/w, one or more solvents in the range of about 50 to about 94% w/w, with or without additive (e.g., isopropanol or ethanol) in the range of about 5 to about 30% w/w, and optionally a plasticizer in the range of about 0.5 to about 25% w/w. The pour-on antiparasitic formulation features limited spreading when applied to animals (cattle, sheep, dogs and the like). The pour-on antiparasitic formulation further partially evaporates, leaving a water resistant polymer matrix that diffuses at least one active ingredient to the animal's skin. | 07-23-2015 |
20160051519 | PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF - This invention relates to topical compositions for combating ectoparasites and endoparasites in animals, comprising at least one isoxazoline active agent and a pharmaceutically acceptable carrier, optionally in combination with one or more additional active agents. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infections and infestations in an animal comprising administering the compositions of the invention to the animal in need thereof. | 02-25-2016 |